Advisory Committee on Blood Safety and AvailabilityPresentations - May 2005Review of May 2005 Advisory Committee Recommendations Mark Brecher, M.D. [PDF - 45KB] Progress and Challenges in the Efficacy, Safety and Paths to Licensure Dorothy Scott, M.D., FDA [PDF - 97KB] Update on IgIV Supply and Reimbursement Patrick M. Schmidt, FFF Enterprises [PDF - 1.66MB] IgIV Supply and Reimbursement Julie Birkofer, Executive Director, PPTA [PDF - 91KB] Immune Deficiency Foundation Michelle B. Vogel, VP of Government Affairs [PDF - 80KB] HHS Pandemic Action Benjamin Schwartz, M.D., CDC [PDF - 516KB] National Association of County and City Health Officials Fernando Guerra, M.D. San Antonio Metropolitan Health District [PDF - 813KB] Association of State and Territorial Health Officials Richard Raymond, M.D., President ASTHO [PDF - 98KB] Council of State and Territorial Epidemiologist Alfred DeMaria, Jr., M.D. Massachusetts Department of Public Health [PDF - 126KB] Models for Disease Reporting and Adverse Event Surveillance UDC Michael Soucie, Ph.D., CDC [PDF - 452KB] National Hospital-based Transfusion Reaction Surveillance using the NHSN Teresa Horan, MPH, Epidemiologist, CDC [PDF - 453KB] Models for Disease Reporting and Adverse Event Surveillance ArborNet Theresa L. Smith, M.D., CDC [PDF - 67KB] FDA Surveillance Programs Robert P. Wise, M.D., MPH, FDA [PDF - 56KB] NHLBI's funded RED-II Program: Understanding the RED-II Program and its Role in Detecting Emerging Threats Michael P. Busch, M.D., Ph.D., Blood Systems Research Institute [PDF - 1.67MB] Orphan Test Development: Removal of TSE Infectivity from Blood and Blood Products by Absorption Robert Rohwer, Ph.D., VA., Baltimore and U of Maryland [PDF - 676KB] PrP-Sc Detection in Blood Alan Rudolph Ph.D., Adlyfe, Inc. [PDF - 463KB] Detection of Protein Conformational Disorders Stuart Wilson, Ph.D., Microsens, UK [PDF - 301KB] Status of Pathogen Reduction Laurence Corash, M.D., Cerus Corporation [PDF - 283KB] Orphan Test Development: Malaria Detection Sanjai Kumar, Ph.D., FDA [PDF - 1.40MB] Chagas, Leishmania, and Bioterror Agents Robert Duncan, Ph.D., FDA [PDF - 932KB] Application of Nanotechnology Dimitra Georganopoulou, PH.D., Northwestern University [PDF - 1.77MB] Detection of New Pathogens Through Surveillance of Bank Sample Eric Delwart, Ph.D., Blood Systems Research Institute [PDF - 1.04MB] Update from Gambro BCT Larry Dumont, Ph.D., Gambro BCT [PDF - 182KB] Update form Pall Stein Holme, Ph.D., Pall BioMedical [PDF - 199KB] Comments from FDA Jaroslav Vostal, M.D., Ph.D., FDA [PDF - 54KB] Public Comments James P. AuBuchon, M.D. [PDF - 117KB]
|